FN1: A novel fusion partner of ALK in an inflammatory myofibroblastic tumor

Inflammatory myofibroblastic tumors (IMTs) are rare tumors characterized as low‐to‐intermediate grade sarcomas. Rearrangements of the anaplastic lymphoma kinase (ALK) gene have been reported in IMT. Here, we describe a novel fusion gene in an IMT tumor specimen. A 12‐year‐old male was admitted to ou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric blood & cancer 2015-05, Vol.62 (5), p.909-911
Hauptverfasser: Ouchi, Kazutaka, Miyachi, Mitsuru, Tsuma, Yusuke, Tsuchiya, Kunihiko, Iehara, Tomoko, Konishi, Eiichi, Yanagisawa, Akio, Hosoi, Hajime
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Inflammatory myofibroblastic tumors (IMTs) are rare tumors characterized as low‐to‐intermediate grade sarcomas. Rearrangements of the anaplastic lymphoma kinase (ALK) gene have been reported in IMT. Here, we describe a novel fusion gene in an IMT tumor specimen. A 12‐year‐old male was admitted to our hospital with a bladder tumor. We identified the fibronectin 1 gene (FN1) as a fusion partner of ALK using 5′RACE. This novel fusion, FN1–ALK, resulted in ALK overexpression in the IMT. This finding should clarify the causes of IMT and facilitate development of novel therapeutics. Pediatr Blood Cancer 2015;62:909–911. © 2015 Wiley Periodicals, Inc.
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.25424